ChemoMetec A/S
ChemoMetec A/S
0,13 %
149,60 DKK
0,20
Kurs
149,60
Hög
150,00
Förändring
0,13 %
Låg
148,00
Uppdaterad
2019-07-19
Öppen
148,80
Factsheet for ChemoMetec A/S
Company Profile
Description
ChemoMetec A/S is specialises in the design, development and production of instruments using patented technology in cell counting and evaluation. It isengaged in the manufacturing, and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include, Advanced Cell Analysis, Counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provide platforms for determination of viability and cell count of yeast, veterinary semen, mammalian cells and somatic cells as well as advanced image analysis.
Key Stats
Website: http://www.chemometec.com
Headquarter country: Denmark
Employees: 36
Market Cap (at close 19-07-2019): DKK 2B
Fiscal Year Ends: juni
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 73,30 54,80 51,60 75,50 93,60
Forward Price/Earnings
Price/Free Cash Flow 148,40 148,30 141,50 136,90 62,70
Return on Assets 17,20 8,00 13,60 13,80 2,30
Return on Equity 26,50 12,40 20,30 17,50 2,60
Return on Invested Capital 20,90 9,70 16,50 16,90 2,80
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 112,69 90,33 85,23 61,24 45,23
Gross Profit 0,10 0,08 0,07 0,05 0,04
Gross Margin % 88,28% 88,78% 84,83% 85,28% 89,86%
Operating Expenses 2018 2017 2016 2015 2014
EBITDA 30,00 15,00 21,00 13,00 7,00
Net income 18,00 7,00 10,00 8,00 1,00
Basic Earnings Per Share 1,17 0,48 0,67 0,51 0,07
Operating Income 0,02 0,01 0,02 0,01 0,00
Operating Margin % 21,55% 11,28% 18,87% 9,52% 3,64%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow 25,00 10,00 17,00 13,00 6,00
Capital Expenditures -16,00 -11,00 -30,00 -9,00 -7,00
Free Cash Flow 9,00 -1,00 -13,00 4,00 -1,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets
Long Term Assets
Total Assets
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities
Long Term Liabilities
Total Liabilities
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings
Treasury Stock
Total Stockholder Equity
Net Tangible Assets